{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T17:10:06Z","timestamp":1779383406797,"version":"3.53.1"},"reference-count":45,"publisher":"Biomedical Research Press","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed. Res."],"published-print":{"date-parts":[[2024,3,22]]},"DOI":"10.2220\/biomedres.45.67","type":"journal-article","created":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T22:14:32Z","timestamp":1711836872000},"page":"67-76","source":"Crossref","is-referenced-by-count":3,"title":["Tenascin-X is increased with decreased expression of miR-378a-5p and miR-486-5p in mice fed a methionine-choline-deficient diet that induces hepatic fibrosis"],"prefix":"10.2220","volume":"45","author":[{"given":"Ken-ichi","family":"MATSUMOTO","sequence":"first","affiliation":[{"name":"Department of Biosignaling and Radioisotope Experiment, Interdisciplinary Center for Science Research, Head Office for Research and Academic Information, Shimane University, 89-1 Enya-cho, Izumo 693-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"HIGUCHI","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biology, Science Research Center, Kochi Medical School, Kochi University, Oko-cho, Kohasu, Nankoku 783-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirei","family":"UMEKI","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biology, Science Research Center, Kochi Medical School, Kochi University, Oko-cho, Kohasu, Nankoku 783-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"ONO","sequence":"additional","affiliation":[{"name":"Division of Innovative Medicine for Hepatobiliary & Pancreatology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"SAKAMOTO","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biology, Science Research Center, Kochi Medical School, Kochi University, Oko-cho, Kohasu, Nankoku 783-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1059","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Ali Syeda Z, Langden SSS, Munkhzul C, Lee M and Song SJ (2020) Regulatory mechanism of microRNA expression in cancer. Int J Mol Sci 21.","DOI":"10.3390\/ijms21051723"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Azimifar SB, Nagaraj N, Cox J, Mann M (2014) Cell-type-resolved quantitative proteomics of murine liver. Cell Metab 20, 1076\u20131087.","DOI":"10.1016\/j.cmet.2014.11.002"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136, 215\u2013233.","DOI":"10.1016\/j.cell.2009.01.002"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Bristow J, Tee MK, Gitelman SE, Mellon SH and Miller WL (1993) Tenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B. J Cell Biol 122, 265\u2013278.","DOI":"10.1083\/jcb.122.1.265"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Bristow J, Carey W, Egging D and Schalkwijk J (2005) Tenascin-X, collagen, elastin, and the Ehlers-Danlos syndrome. Am J Med Genet C Semin Med Genet 139c, 24\u201330.","DOI":"10.1002\/ajmg.c.30071"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Csak T, Bala S, Lippai D, Satishchandran A, Catalano D, et al. (2015) MicroRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis. Liver Int 35, 532\u2013541.","DOI":"10.1111\/liv.12633"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Demirdas S, Dulfer E, Robert L, Kempers M, van Beek D, et al. (2017) Recognizing the tenascin-X deficient type of Ehlers-Danlos syndrome: a cross-sectional study in 17 patients. Clin Genet 91, 411\u2013425.","DOI":"10.1111\/cge.12853"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Dey BK, Gagan J and Dutta A (2011) miR-206 and -486 induce myoblast differentiation by downregulating Pax7. Mol Cell Biol 31, 203\u2013214.","DOI":"10.1128\/MCB.01009-10"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Du J, Niu X, Wang Y, Kong L, Wang R, et al. (2015) MiR-146a-5p suppresses activation and proliferation of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis through directly targeting Wnt1 and Wnt5a. Sci Rep 5, 16163.","DOI":"10.1038\/srep16163"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Endo T, Ariga H and Matsumoto K (2009) Truncated form of tenascin-X, XB-S, interacts with mitotic motor kinesin Eg5. Mol Cell Biochem 320, 53\u201366.","DOI":"10.1007\/s11010-008-9898-y"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Ezhilarasan D (2020) MicroRNA interplay between hepatic stellate cell quiescence and activation. Eur J Pharmacol 885, 173507.","DOI":"10.1016\/j.ejphar.2020.173507"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Hirose A, Ono M, Saibara T, Nozaki Y, Masuda K, et al. (2007) Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis. Hepatology 45, 1375\u20131381.","DOI":"10.1002\/hep.21638"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Hyun J, Wang S, Kim J, Rao KM, Park SY, et al. (2016) MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression. Nat Commun 7, 10993.","DOI":"10.1038\/ncomms10993"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Ikuta T, Sogawa N, Ariga H, Ikemura T and Matsumoto K (1998) Structural analysis of mouse tenascin-X: evolutionary aspects of reduplication of FNIII repeats in the tenascin gene family. Gene 217, 1\u201313.","DOI":"10.1016\/S0378-1119(98)00355-2"},{"key":"15","unstructured":"Itagaki H, Shimizu K, Morikawa S, Ogawa K and Ezaki T (2013) Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL\/6 mice. Int J Clin Exp Pathol 6, 2683\u20132696."},{"key":"16","doi-asserted-by":"crossref","unstructured":"Ji X, Wu B, Fan J, Han R, Luo C, et al. (2015) The anti-fibrotic effects and mechanisms of microRNA-486-5p in pulmonary fibrosis. Sci Rep 5, 14131.","DOI":"10.1038\/srep14131"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Katsura A, Morishita A, Iwama H, Tani J, Sakamoto T, et al. (2015) MicroRNA profiles following metformin treatment in a mouse model of non-alcoholic steatohepatitis. Int J Mol Med 35, 877\u2013884.","DOI":"10.3892\/ijmm.2015.2092"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Kong L, An X, Hu L, Zhang S, Liu L, et al. (2022) Resveratrol ameliorates nutritional steatohepatitis through the mmu-miR-599\/PXR pathway. Int J Mol Med 49.","DOI":"10.3892\/ijmm.2022.5102"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Krol J, Loedige I and Filipowicz W (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11, 597\u2013610.","DOI":"10.1038\/nrg2843"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Loyer X, Paradis V, He\u0301nique C, Vion AC, Colnot N, et al. (2016) Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPAR\u03b1 expression. Gut 65, 1882\u20131894.","DOI":"10.1136\/gutjnl-2014-308883"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Matsumoto K, Saga Y, Ikemura T, Sakakura T and Chiquet-Ehrismann R (1994) The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C. J Cell Biol 125, 483\u2013493.","DOI":"10.1083\/jcb.125.2.483"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Matsumoto K, Kinoshita T, Hirose T and Ariga H (2006) Characterization of mouse serum tenascin-X. DNA Cell Biol 25, 448\u2013456.","DOI":"10.1089\/dna.2006.25.448"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Matsumoto K and Aoki H (2020) The roles of tenascins in cardiovascular, inflammatory, and heritable connective tissue diseases. Front Immunol 11, 609752.","DOI":"10.3389\/fimmu.2020.609752"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Matsumoto K, Kawakami K, Yamada K and Takeshita H (2022) COL1A1 expression induced by overexpression of both a 15-amino acid peptide from the fibrinogen domain of tenascin-X and integrin \u03b111 in LX-2 cells. Mol Med Rep 26, 330.","DOI":"10.3892\/mmr.2022.12846"},{"key":"25","unstructured":"Nakagami H, Shimamura M, Miyake T, Shimosato T, Minobe N, et al. (2012) Nifedipine prevents hepatic fibrosis in a non-alcoholic steatohepatitis model induced by an L-methionine- and choline-deficient diet. Mol Med Rep 5, 37\u201340."},{"key":"26","doi-asserted-by":"crossref","unstructured":"Okuda-Ashitaka E and Matsumoto K (2023) Tenascin-X as a causal gene for classical-like Ehlers-Danlos syndrome. Front Genet 14, 1107787.","DOI":"10.3389\/fgene.2023.1107787"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Otsuka M, Jing Q, Georgel P, New L, Chen J, et al. (2007) Hypersusceptibility to vesicular stomatitis virus infection in Dicer1-deficient mice is due to impaired miR24 and miR93 expression. Immunity 27, 123\u2013134.","DOI":"10.1016\/j.immuni.2007.05.014"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Piersma B, Bank RA and Boersema M (2015) Signaling in fibrosis: TGF-\u03b2, WNT, and YAP\/TAZ converge. Front Med (Lau- sanne) 2, 59.","DOI":"10.3389\/fmed.2015.00059"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Roehlen N, Crouchet E and Baumert TF (2020) Liver fibrosis: mechanistic concepts and therapeutic perspectives. Cells 9, 875.","DOI":"10.3390\/cells9040875"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Sakamoto S and Taniguchi T (2001) Identification of a phorbol ester-responsive element in the interferon-gamma receptor 1 chain gene. J Biol Chem 276, 37237\u201337241.","DOI":"10.1074\/jbc.M105543200"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Schalkwijk J, Zweers MC, Steijlen PM, Dean WB, Taylor G, et al. (2001) A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency. N Engl J Med 345, 1167\u20131175.","DOI":"10.1056\/NEJMoa002939"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Todaka H, Higuchi T, Yagyu K, Sugiyama Y, Yamaguchi F, et al. (2015) Overexpression of NF90-NF45 represses myogenic microRNA biogenesis, resulting in development of skeletal muscle atrophy and centronuclear muscle fibers. Mol Cell Biol 35, 2295\u20132308.","DOI":"10.1128\/MCB.01297-14"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Tucker RP, Drabikowski K, Hess JF, Ferralli J, Chiquet- Ehrismann R, et al. (2006) Phylogenetic analysis of the tenascin gene family: evidence of origin early in the chordate lineage. BMC Evol Biol 6, 60.","DOI":"10.1186\/1471-2148-6-60"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Valcourt U, Alcaraz LB, Exposito JY, Lethias C and Bartholin L (2015) Tenascin-X: beyond the architectural function. Cell Adh Migr 9, 154\u2013165.","DOI":"10.4161\/19336918.2014.994893"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Vettori S, Gay S and Distler O (2012) Role of microRNAs in fibrosis. Open Rheumatol J 6, 130\u2013139.","DOI":"10.2174\/1874312901206010130"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Wang Y, Du J, Niu X, Fu N, Wang R, et al. (2017) MiR-130a-3p attenuates activation and induces apoptosis of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis by directly targeting TGFBR1 and TGFBR2. Cell Death Dis 8, e2792.","DOI":"10.1038\/cddis.2017.10"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Xu L, Hui AY, Albanis E, Arthur MJ, O\u2019Byrne SM, et al. (2005) Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut 54, 142\u2013151.","DOI":"10.1136\/gut.2004.042127"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Yamaguchi S, Kawakami K, Satoh K, Fukunaga N, Akama K, et al. (2017) Suppression of hepatic dysfunction in tenascin-X-deficient mice fed a high-fat diet. Mol Med Rep 16, 4061\u20134067.","DOI":"10.3892\/mmr.2017.7052"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Yang L, Dong C, Yang J, Yang L, Chang N, et al. (2019) MicroRNA-26b-5p inhibits mouse liver fibrogenesis and angiogenesis by targeting PDGF receptor-beta. Mol Ther Nucleic Acids 16, 206\u2013217.","DOI":"10.1016\/j.omtn.2019.02.014"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Yang YL, Wang PW, Wang FS, Lin HY and Huang YH (2020) miR-29a modulates GSK3\u03b2\/SIRT1-linked mitochondrial proteostatic stress to ameliorate mouse non-alcoholic steatohepatitis. Int J Mol Sci 21, 6884.","DOI":"10.3390\/ijms21186884"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Yanguas SC, Cogliati B, Willebrords J, Maes M, Colle I, et al. (2016) Experimental models of liver fibrosis. Arch Toxicol 90, 1025\u20131048.","DOI":"10.1007\/s00204-015-1543-4"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Zhang DY, Goossens N, Guo J, Tsai MC, Chou HI, et al. (2016) A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resection. Gut 65, 1754\u20131764.","DOI":"10.1136\/gutjnl-2015-309655"},{"key":"43","doi-asserted-by":"crossref","unstructured":"Zhang Y, Wang Y, Ji H, Ding J and Wang K (2022) The interplay between noncoding RNA and YAP\/TAZ signaling in cancers: molecular functions and mechanisms. J Exp Clin Cancer Res 41, 202.","DOI":"10.1186\/s13046-022-02403-4"},{"key":"44","doi-asserted-by":"crossref","unstructured":"Zhao H, Feng YL, Liu T, Wang JJ and Yu J (2021a) MicroRNAs in organ fibrosis: From molecular mechanisms to potential therapeutic targets. Pathol Res Pract 225, 153588.","DOI":"10.1016\/j.prp.2021.153588"},{"key":"45","doi-asserted-by":"crossref","unstructured":"Zhao H, Yang H, Geng C, Chen Y, Tang Y, et al. (2021b) Elevated IgE promotes cardiac fibrosis by suppressing miR-486a-5p. Theranostics 11, 7600\u20137615.","DOI":"10.7150\/thno.47845"}],"container-title":["Biomedical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/biomedres\/45\/2\/45_67\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T05:19:39Z","timestamp":1712380779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/biomedres\/45\/2\/45_67\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,22]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2220\/biomedres.45.67","relation":{},"ISSN":["0388-6107","1880-313X"],"issn-type":[{"value":"0388-6107","type":"print"},{"value":"1880-313X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,22]]}}}